Avanos Medical (AVNS) Operating Expenses (2013 - 2026)

Avanos Medical's Operating Expenses history runs 14 years deep, the most recent figure standing at $82.9 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 2.22% year-over-year to $82.9 million; the TTM figure through Mar 2026 stood at $340.7 million (up 1.64% YoY), while the FY2025 annual figure was $338.9 million, down 1.68% from the prior year.
• Operating Expenses came in at $82.9 million for Q1 2026 at Avanos Medical, down from $84.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $99.8 million in Q2 2023 to a low of $81.1 million in Q1 2025.
• A 5-year average of $87.6 million and a median of $85.4 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses increased 29.95% in 2022 and declined 12.63% in 2024, its largest moves.
• Avanos Medical's Operating Expenses stood at $85.9 million in 2022, then fell by 5.36% to $81.3 million in 2023, then advanced by 5.04% to $85.4 million in 2024, then decreased by 0.59% to $84.9 million in 2025, then declined by 2.36% to $82.9 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $82.9 million, $84.9 million, and $83.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison